IFP Advisors Inc Makes New Investment in Ultralife Co. (NASDAQ:ULBI)

IFP Advisors Inc bought a new stake in Ultralife Co. (NASDAQ:ULBIFree Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 11,400 shares of the technology company’s stock, valued at approximately $85,000. IFP Advisors Inc owned 0.07% of Ultralife as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently modified their holdings of the business. Janney Montgomery Scott LLC boosted its position in shares of Ultralife by 0.9% in the fourth quarter. Janney Montgomery Scott LLC now owns 447,000 shares of the technology company’s stock valued at $3,330,000 after acquiring an additional 3,850 shares during the period. JPMorgan Chase & Co. boosted its position in shares of Ultralife by 250.8% in the third quarter. JPMorgan Chase & Co. now owns 47,458 shares of the technology company’s stock valued at $429,000 after acquiring an additional 33,929 shares during the period. Barclays PLC boosted its position in shares of Ultralife by 21.3% in the third quarter. Barclays PLC now owns 13,395 shares of the technology company’s stock valued at $121,000 after acquiring an additional 2,355 shares during the period. Geode Capital Management LLC boosted its position in shares of Ultralife by 1.2% in the third quarter. Geode Capital Management LLC now owns 232,681 shares of the technology company’s stock valued at $2,104,000 after acquiring an additional 2,835 shares during the period. Finally, Jane Street Group LLC bought a new stake in shares of Ultralife in the third quarter valued at about $166,000. Institutional investors own 30.68% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Benchmark reaffirmed a “buy” rating and issued a $14.00 price target on shares of Ultralife in a research note on Friday, November 15th.

Get Our Latest Research Report on Ultralife

Ultralife Stock Up 2.6 %

ULBI stock opened at $6.02 on Thursday. The company has a market cap of $100.09 million, a PE ratio of 10.95 and a beta of 0.96. The business has a 50-day simple moving average of $7.35 and a 200 day simple moving average of $8.28. Ultralife Co. has a 52 week low of $5.79 and a 52 week high of $13.39. The company has a quick ratio of 1.62, a current ratio of 3.30 and a debt-to-equity ratio of 0.04.

About Ultralife

(Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

See Also

Want to see what other hedge funds are holding ULBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ultralife Co. (NASDAQ:ULBIFree Report).

Institutional Ownership by Quarter for Ultralife (NASDAQ:ULBI)

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.